Specialty pharmacists serve as the primary coordinators of care for patients with rare, chronic, and progressive conditions requiring complex medications, balancing clinical efficacy with the necessity of sustainable health care resource utilization. The satellite symposia presented during this year's Asembia's AXS26 Summit are dedicated to empowering pharmacists as they navigate the rapid evolution of specialty therapeutics across a broad range of disease states. Programs will address oncology and hematologic malignancies, including oral therapies, treatment sequencing, and the use of precision medicine. Sessions will also cover rare and progressive conditions, evolving landscapes in immunology, and long-term treatment success in chronic conditions with new and emerging therapies. Across these sessions, attendees will examine recent clinical evidence and appropriate medication use from both a specialty and managed care perspective to better understand administration protocols, formulary evaluation and utilization management, and support timely access to therapies. To connect clinical data with real-world practice, select sessions will feature patient case discussions that highlight the practical impact of pharmacist-led interventions.
Target Audience
Managed care pharmacists, specialty pharmacists
View the agenda to learn more about each satellite symposia.
Accreditation Information
Pharmacy Times Continuing Education™ is accredited by the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing pharmacy education.
Obtaining Credit
All participants who attended the live virtual broadcast must log in to their Pharmacy Times Continuing Education™ account at www.pharmacytimes.org to complete an online evaluation and request their credit. Instructions on receiving credit will be provided on the day of the event.